We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

73 hedge funds and large institutions have $735M invested in Sage Therapeutics in 2014 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

160% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 10

40% more funds holding

Funds holding: 52 → 73 (+21)

23% more capital invested

Capital invested by funds: $596M → $735M (+$140M)

Holders
73
Holders Change
+21
Holders Change %
+40.38%
% of All Funds
1.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
28
Increased
26
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$11.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.09M
3
JP Morgan Chase
JP Morgan Chase
New York
+$4.45M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.03M
5
Stifel Financial
Stifel Financial
Missouri
+$3.74M

Top Sellers

1
DM
Deerfield Management
New York
-$7.01M
2
PA
Perceptive Advisors
New York
-$5.15M
3
O
OrbiMed
New York
-$4.66M
4
Millennium Management
Millennium Management
New York
-$2.52M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
51
Spark Investment Management
New York
$245K +$250K +6,700 New
Swiss National Bank
52
Swiss National Bank
Switzerland
$201K +$205K +5,500 New
TCM
53
Tekla Capital Management
Massachusetts
$183K – – –
MLICM
54
Metropolitan Life Insurance Company (MetLife)
New York
$171K -$135K -3,609 -44%
SG Americas Securities
55
SG Americas Securities
New York
$158K +$160K +4,305 New
AIG
56
American International Group
New York
$132K +$135K +3,615 New
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$104K +$106K +2,833 New
SO
58
STRS Ohio
Ohio
$73K – – –
Morgan Stanley
59
Morgan Stanley
New York
$72K +$4.32K +116 +6%
CAM
60
Cormorant Asset Management
Massachusetts
$37K -$335K -9,000 -90%
BPBT
61
Boston Private Bank & Trust
Massachusetts
$37K +$37.3K +1,000 New
UBS Group
62
UBS Group
Switzerland
$23K +$23.9K +641 New
MAA
63
Managed Account Advisors
New Jersey
$22K +$75 +2 +0.3%
Barclays
64
Barclays
United Kingdom
$21K +$21.1K +567 New
BJ
65
BlackRock Japan
Japan
$18K +$3.47K +93 +23%
SFU
66
Stonehage Fleming (UK)
United Kingdom
$16K +$16.2K +435 New
Bank of America
67
Bank of America
North Carolina
$11K +$11.2K +300 New
Wells Fargo
68
Wells Fargo
California
$10K +$9.95K +267 New
Teacher Retirement System of Texas
69
Teacher Retirement System of Texas
Texas
$7K +$7.27K +195 New
Creative Planning
70
Creative Planning
Kansas
$4K – – –
SEI Investments
71
SEI Investments
Pennsylvania
$2K +$2.31K +62 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$160 +$163K +4,372 New
Millennium Management
73
Millennium Management
New York
– -$2.52M -80,078 Closed
LCM
74
Landscape Capital Management
New Jersey
– -$697K -22,116 Closed
HHC
75
Hutchin Hill Capital
New York
– -$315K -10,000 Closed
1 2
3
4

SAGE Hedge Fund Activity: Q4 2014 in Review

73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2014, worth a combined $735M — up 23% from $596M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 6 closed out — a net gain of 22 holders — while 26 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $11.9M. The largest seller was Deerfield Management, cutting an estimated $7.01M.

  • 73 institutional investors held Sage Therapeutics (SAGE) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $735M of Sage Therapeutics stock for Q4 2014, up 23% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q4 2014 and 6 closed out, a net change of +22 holders.
  • The largest Sage Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $11.9M added.
  • The largest Sage Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $7.01M sold.

Based on aggregated 13F filings for Q4 2014.